Merck & Co Inc (NYSE:MRK) has a beta value of 0.40 and has seen 6.79 million shares traded in the last trading session. The company, currently valued at $329.55B, closed the last trade at $130.12 per share which meant it lost -$1.08 on the day or -0.82% during that session. The MRK stock price is -2.29% off its 52-week high price of $133.10 and 23.81% above the 52-week low of $99.14. The 3-month trading volume is 8.43 million shares.

Merck & Co Inc (NYSE:MRK) trade information

Sporting -0.82% in the red in last session, the stock has traded in the green over the last five days, when the MRK stock price touched $130.12 or saw a rise of 2.02%. Year-to-date, Merck & Co Inc shares have moved 19.35%, while the 5-day performance has seen it change 2.51%. Over the past 30 days, the shares of Merck & Co Inc (NYSE:MRK) have changed -1.39%.

Merck & Co Inc (MRK) estimates and forecasts

Figures show that Merck & Co Inc shares have outperformed across the wider relevant industry. The company’s shares have gained 23.28% over the past 6 months, with this year growth rate of 470.20%, compared to 3.90% for the industry. Other than that, the company has, however, increased its growth outlook for the 2024 fiscal year revenue. Growth estimates for the current quarter are 203.40% and 20.60% for the next quarter. Revenue growth from the last financial year stood is estimated to be 6.60%.

16 analysts offering their estimates for the company have set an average revenue estimate of $15.83 billion for the current quarter. 15 have an estimated revenue figure of $16.68 billion for the next quarter concluding in Sep 2024. Year-ago sales stood $15.04 billion and $14.56 billion respectively for this quarter and the next, and analysts expect sales will grow by 5.30% for the current quarter and 14.60% for the next.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -42.70% over the past 5 years. Earnings growth for 2024 is a modest 470.68% while over the next 5 years, the company’s earnings are expected to increase by 67.38%.

MRK Dividends

Merck & Co Inc is expected to release its next earnings report in May this year, and investors are excited at the prospect of better dividends despite the company’s debt issue. The forward dividend is 3.00 at a share yield of 2.31%. The company’s dividend yield has gone up over the past 12 months.